TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tryptamine Therapeutics ( (AU:TYP) ) has issued an announcement.
Tryptamine Therapeutics Limited announced the quotation of 165,588,237 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 18, 2025. This move is part of previously announced transactions and could enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing access to capital and expanding its investor base.
More about Tryptamine Therapeutics
Tryptamine Therapeutics Limited operates in the pharmaceutical industry, focusing on the development and commercialization of therapeutic products. The company is primarily engaged in creating innovative treatments, potentially targeting mental health and neurological conditions.
Average Trading Volume: 2,495,811
Technical Sentiment Signal: Buy
Current Market Cap: A$51.98M
For detailed information about TYP stock, go to TipRanks’ Stock Analysis page.